We have developed the recombinant adeno-associated virus (AAV) carrying the EGFP gene under the control of the microphtalmia-associated transcription factor-M (MITF-M) promoter region for melanoma-specific expression. MITF-M distal enhancer (MDE) region enhances the specific expression of the reporter gene specifically in cultured melanoma cells. Expression of EGFP protein was very high in AAV-CMV-EGFP infected cells but relatively low in cells infected with AAV-Mitf(Enh/Pro)-EGFP. After an in vitro infection by a recombinant AAV carrying the EGFP gene under the control of human MITF-M promoter, the reporter gene was expressed in MITF-M producing melanoma cell lines (SK-28 and G361), but not in MITF-M non-producing cell lines (HaCat). These results suggest that the utilization of the MITF-M promoter in a recombinant AAV vector could provide benefits in gene therapy applications.
INTRODUCTION
Among the vectors which can be considered for therapeutic application to skin, adeno-associated virus (AAV) seems to possess several appealing features, including the capacity to promote long-term expression of the therapeutic gene in the absence of signs of inflammation or immune response (1) . These vectors are derived from a nonpathogenic and widespread defective parvovirus, and are able to transduce dividing or non-dividing cells, including skeletal and cardiac muscle (2, 3), brain (4) and liver (5).
Microphtalmia-associated transcription factor-M (MITF-M) is essential for differentiation of melanoblasts to melanocytes and contains a basic helix-loop-helix leucine zipper (bHLH-LZ) structure (6, 7) . This gene is exclusively expressed in melanocytes and melanoma cells, and is under the control of the MITF-M promoter (7~9). Fuse et al. (1996) published that the segment (position -387 to transcription initiation site) contains the putative promoter region (9) . A TATA-like sequence is located at position -21. In this study, we constructed recombinant AAV carrying the EGFP gene under the control of the MITF-M promoter region for melanoma-specific expression. The enhancer and 57 promoter region resulted in melanocyte-specific expression of the reporter gene specifically in cultured melanoma cells.
We showed that the control of the melanocyte-specific promoter in the recombinant AAV significantly increase the specificity of expression of human melanoma cell lines.
MATERIALS AND METHODS

Reagents and cells
Taq DNA polymerase and the AAV helper free system were purchased from Promega (Madison, WI) and 
Plasmid DNAs construction
The genomic DNA was isolated from the human skin (Enh/Pro)-EGFP as described previously (13) . Cells were incubated in complete medium for 4 or 5 days. The transduction efficiency was measured by EGFP imaging using a NIKON fluorescence microscope (Nikon, Inc., Japan).
RESULTS AND DISCUSSION
The pAAV-CMV-EGFP plasmid DNA was generated by 
